Disc Medicine, Inc.

IRON

Disc Medicine, Inc.

IRON

Insider Sentiment (TTM):

Last Purchase:2024-06-17Last Sale:2026-06-29Shares Purchased (TTM):0Shares Sold (TTM):1,172,974

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:38,897,813Shares Outstanding:38,491,433Institutional Ownership Pct.:101.06%

Earnings Market Reaction:

Filing Date:2026-07-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	99	89	91	141	127	123	192	193	281	343	360	371
Marketable Securities Current	619	641	700	475	523	572	297	295	220	-	0	-
Prepaid Expense And Other Assets Current	15	17	13	11	12	11	4	6	7	9	5	4
Assets Current	733	747	804	627	662	706	494	493	508	352	366	374
Property Plant And Equipment Net	1	1	1	1	1	1	1	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	1	1	1	1	2	2	2	2	2	2
Other Assets Noncurrent	0	1	1	1	1	1	1	0	0	0	0	0
Assets	735	750	807	630	665	709	497	495	510	354	368	376
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	7	12	9	7	6	7	8	4	5	5	13	8
Accrued Liabilities Current	9	7	16	11	6	4	8	6	4	9	6	6
Operating Lease Liability Current	0	0	1	1	1	0	0	0	1	1	1	0
Liabilities Current	30	31	37	27	21	19	23	25	20	15	21	14
Long Term Debt	59	29	29	29	29	29	28	-	-	-	0	-
Operating Lease Liability Noncurrent	1	1	1	1	2	2	2	2	1	1	1	2
Asset Acquisition Contingent Consideration Liabili…	-	-	-	-	-	-	-	-	-	-	-	2
Liabilities	91	62	67	57	51	49	53	27	21	16	23	18
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	-	-	-	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,279	1,263	1,249	1,022	1,001	992	741	736	731	554	534	524
Accumulated Other Comprehensive Income Loss Net Of…	-2	-1	1	1	0	1	0	1	-0	-	0	-
Retained Earnings Accumulated Deficit	-633	-574	-510	-450	-387	-332	-298	-269	-242	-216	-189	-165
Stockholders Equity	644	688	740	573	614	660	444	468	489	338	345	359
Liabilities And Stockholders Equity	735	750	807	630	665	709	497	495	510	354	368	376
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	-	-	-	0	-
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	-	-	-	10	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	-	-	-	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	38	38	38	35	35	35	30	30	30	25	24	24
Shares Outstanding	38	38	38	35	35	35	30	30	30	25	24	24

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.93%	10.64%	9.66%	-	-	-	-	-	-	-	-	-
2025	7.19%	25.14%	39.17%	4.51%	14.86%	50.04%	7.31%	-7.67%	-12.26%	-14.34%	5.68%	-1.55%
2024	10.33%	46.47%	48.42%	18.60%	16.85%	7.37%	2.47%	0.89%	-11.79%	-4.15%	-22.63%	-11.76%
2023	-	-	-	-0.79%	-11.22%	-17.89%	15.20%	19.31%	33.07%	-48.17%	-50.56%	-36.30%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	24.14	24.00	21.94	23.45	32.11	37.65	21.17	19.36	25.02	23.70	17.06	25.96
Quick Ratio	23.64	23.45	21.59	23.03	31.54	37.07	21.01	19.13	24.66	23.07	16.81	25.70
Working Capital	702.40M	716.31M	767.26M	600.42M	640.99M	686.86M	470.30M	467.68M	487.93M	337.10M	344.22M	359.85M
Leverage & Debt
Debt to Equity	0.14	0.09	0.09	0.10	0.08	0.07	0.12	0.06	0.04	0.05	0.07	0.05
Interest Coverage TTM	-75.81	-74.73	-65.43	-61.77	-70.94	-94.08	-226.78	-	-	-	-	-
Debt Ratio	0.12	0.08	0.08	0.09	0.08	0.07	0.11	0.05	0.04	0.05	0.06	0.05
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-6.36	-6.28	-6.01	-5.15	-4.15	-3.50	-3.96	-3.46	-3.55	-3.25	-3.42	-2.64
Free Cash Flow Per Share TTM	-5.11	-5.23	-5.14	-4.72	-3.87	-3.09	-3.42	-2.81	-2.90	-2.89	-3.30	-2.69
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	69.13%	107.40%	94.03%	75.02%	59.76%	44.54%	43.08%	61.45%	37.63%	34.88%	63.22%	266.13%
EPS Growth (1Y)	53.12%	79.56%	51.76%	48.94%	17.00%	7.61%	15.66%	31.15%	15.28%	3.05%	-92.40%	-85.54%
Valuation Metrics
P/E TTM	-11.51	-10.19	-13.21	-12.84	-12.76	-14.20	-16.00	-14.22	-12.70	-19.17	-16.86	-17.82
P/B TTM	4.39	3.58	3.79	4.05	3.02	2.51	3.95	3.14	2.36	4.57	3.73	3.18
Market Cap	2.83B	2.46B	2.80B	2.32B	1.85B	1.65B	1.75B	1.47B	1.16B	1.54B	1.29B	1.14B
Enterprise Value	2.79B	2.40B	2.74B	2.21B	1.76B	1.56B	1.59B	1.28B	875.10M	1.20B	928.35M	771.75M
Calculated Values
Free Cash Flow TTM	-197.58M	-201.34M	-181.33M	-166.03M	-135.57M	-103.01M	-94.45M	-84.23M	-74.38M	-71.72M	-73.55M	-65.43M
Net Debt	-39.58M	-59.79M	-62.23M	-111.96M	-98.84M	-94.39M	-164.35M	-192.87M	-280.90M	-342.85M	-360.62M	-370.66M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Sale

Owner: Khara, Rahul

Title: Chief Legal Officer

Shares: 1,649

Price/Share: $75.00

Value: $123,675.00

Shares Owned: 52,173

Relationship: Officer

Ownership: Direct

2026-06-26Sale

Owner: Yu, Jonathan Yen-Wen

Title: Chief Operating Officer

Shares: 300

Price/Share: $72.50

Value: $21,750.00

Shares Owned: 54,324

Relationship: Officer

Ownership: Direct

2026-06-22Sale

Owner: Yu, Jonathan Yen-Wen

Title: Chief Operating Officer

Shares: 9,700

Price/Share: $72.66

Value: $704,802.00

Shares Owned: 54,324

Relationship: Officer

Ownership: Direct

2026-06-18Sale

Owner: Quisel, John D

Title: Chief Executive Officer

Shares: 34,000

Price/Share: $70.74

Value: $2,405,160.00

Shares Owned: 226,064

Relationship: Director,Officer

Ownership: Direct

2026-06-18Sale

Owner: Khara, Rahul

Title: Chief Legal Officer

Shares: 7,500

Price/Share: $70.76

Value: $530,700.00

Shares Owned: 52,173

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Khara, Rahul	Officer	Chief Legal Officer	Direct	Sale	1,649	75.00	$123,675.00	52,173	4
2026-06-26	Yu, Jonathan Yen-Wen	Officer	Chief Operating Officer	Direct	Sale	300	72.50	$21,750.00	54,324	4
2026-06-22	Yu, Jonathan Yen-Wen	Officer	Chief Operating Officer	Direct	Sale	9,700	72.66	$704,802.00	54,324	4
2026-06-18	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	34,000	70.74	$2,405,160.00	226,064	4
2026-06-18	Khara, Rahul	Officer	Chief Legal Officer	Direct	Sale	7,500	70.76	$530,700.00	52,173	4
2026-06-16	Yu, Jonathan Yen-Wen	Officer	Chief Operating Officer	Direct	Sale	18,612	69.34	$1,290,556.08	54,324	4
2026-04-14	Franchi, Jean M.	Officer	Chief Financial Officer	Direct	Sale	6,257	69.24	$433,234.68	64,333	4
2026-04-13	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	5,731	66.46	$380,882.26	79,480	4
2026-03-02	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	7,378	65.96	$486,652.88	85,211	4
2026-02-25	Franchi, Jean M.	Officer	Chief Financial Officer	Direct	Sale	353	69.06	$24,378.18	70,990	4
2026-02-18	Franchi, Jean M.	Officer	Chief Financial Officer	Direct	Sale	7,081	65.45	$463,451.45	71,343	4
2026-02-17	Yu, Jonathan Yen-Wen	Officer	Chief Operating Officer	Direct	Sale	3,231	62.86	$203,100.66	54,324	4
2026-02-17	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	3,256	62.86	$204,672.16	92,589	4
2026-02-17	Stephenson, Pamela	Officer	Chief Commercial Officer	Direct	Sale	5,531	62.86	$347,678.66	80,998	4
2026-02-17	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	13,264	62.86	$833,775.04	226,064	4
2026-02-17	Khara, Rahul	Officer	Chief Legal Officer	Direct	Sale	2,853	62.86	$179,339.58	52,173	4
2026-01-20	Khara, Rahul	Officer	Chief Legal Officer	Direct	Sale	1,000	69.74	$69,740.00	37,793	4
2026-01-02	Khara, Rahul	Officer	Chief Legal Officer	Direct	Sale	6,500	78.52	$510,380.00	37,793	4
2025-12-17	Bitterman, Kevin	Director	-	Indirect	Sale	754	91.47	$68,968.38	14,013	4
2025-12-16	Bitterman, Kevin	Director	-	Indirect	Sale	68,923	91.24	$6,288,534.52	14,161	4
2025-12-15	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	13,093	91.42	$1,196,962.06	75,702	4
2025-12-11	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	40,000	92.45	$3,698,000.00	171,828	4
2025-11-11	Yu, Jonathan Yen-Wen	Officer	Chief Operating Officer	Direct	Sale	30,000	84.60	$2,538,000.00	40,555	4
2025-10-22	Ai, Dmi Llc, Access Indus…	TenPercentOwner	-	Direct	Sale	744,047	80.47	$59,873,462.09	2,814,379	4
2025-10-17	Bitterman, Kevin	Director	-	Indirect	Sale	70,000	88.51	$6,195,700.00	385,549	4
2025-10-08	Bitterman, Kevin	Director	-	Indirect	Sale	71,961	70.40	$5,066,054.40	500,621	4
2025-08-22	Bitterman, Kevin	Director	-	Indirect	Sale	2,287	61.03	$139,575.61	590,621	4
2025-08-14	Bitterman, Kevin	Director	-	Indirect	Sale	7,212	60.99	$439,859.88	592,908	4
2025-08-05	Bitterman, Kevin	Director	-	Indirect	Sale	395	60.95	$24,075.25	625,082	4
2025-07-30	Bitterman, Kevin	Director	-	Indirect	Sale	8,492	61.04	$518,351.68	625,477	4
2025-07-24	Bitterman, Kevin	Director	-	Indirect	Sale	13,033	61.17	$797,228.61	633,969	4
2025-07-18	Bitterman, Kevin	Director	-	Indirect	Sale	664	61.13	$40,590.32	676,839	4
2025-07-17	Franchi, Jean M.	Officer	Chief Financial Officer	Direct	Sale	2,031	59.00	$119,829.00	63,499	4
2025-07-10	Franchi, Jean M.	Officer	Chief Financial Officer	Direct	Sale	2,000	57.50	$115,000.00	65,530	4
2025-07-09	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	34,800	55.72	$1,939,056.00	161,828	4
2025-07-03	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	5,200	55.09	$286,468.00	161,828	4
2025-06-16	Franchi, Jean M.	Officer	Chief Financial Officer	Direct	Sale	2,000	52.26	$104,520.00	67,530	4
2025-06-06	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	2,996	50.00	$149,800.00	56,725	4
2025-05-20	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	6,677	50.04	$334,117.08	59,721	4
2025-05-02	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	2,100	50.17	$105,357.00	66,398	4
2025-03-24	Orbimed, Advisors Llc, Or…	Director	-	Indirect	Sale	5,738	54.11	$310,483.18	186,541	4
2025-03-24	Ashiya, Mona	Director	-	Indirect	Sale	5,738	54.11	$310,483.18	186,541	4
2025-03-21	Orbimed, Capital Gp Vi Ll…	Director	-	Indirect	Sale	10,011	54.00	$540,594.00	187,297	4
2025-03-19	Ashiya, Mona	Director	-	Indirect	Sale	39,656	54.02	$2,142,217.12	188,981	4
2025-03-12	Ashiya, Mona	Director	-	Indirect	Sale	83,182	54.74	$4,553,382.68	194,209	4
2025-03-12	Orbimed, Capital Gp Vi Ll…	Director	-	Indirect	Sale	83,182	54.74	$4,553,382.68	194,209	4
2025-02-18	Franchi, Jean M.	Officer	Chief Financial Officer	Direct	Sale	3,136	54.58	$171,162.88	69,530	4
2025-02-18	Khara, Rahul	Officer	Chief Legal Officer	Direct	Sale	1,161	54.58	$63,367.38	37,583	4
2025-02-18	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	1,638	54.58	$89,402.04	68,498	4
2025-02-18	Stephenson, Pamela	Officer	Chief Commercial Officer	Direct	Sale	3,137	54.58	$171,217.46	69,529	4
2025-02-18	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	5,574	54.58	$304,228.92	154,828	4
2025-02-18	Yu, Jonathan Yen-Wen	Officer	Chief Operating Officer	Direct	Sale	1,610	54.58	$87,873.80	40,555	4
2025-02-03	Khara, Rahul	Officer	Chief Legal Officer	Direct	Sale	7,500	55.70	$417,750.00	14,035	4
2025-01-02	Khara, Rahul	Officer	Chief Legal Officer	Direct	Sale	7,500	63.01	$472,575.00	14,035	4
2024-12-30	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	13,012	62.14	$808,565.68	72,065	4
2024-12-23	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	19,820	63.10	$1,250,642.00	72,065	4
2024-12-16	Quisel, John D	Director,Officer	Chief Executive Officer	Direct	Sale	12,791	65.95	$843,566.45	72,065	4
2024-12-02	White, William Richard	Director	-	Direct	Sale	1,957	64.47	$126,167.79	0	4
2024-11-25	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	14,183	65.93	$935,085.19	40,405	4
2024-11-15	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	9,158	60.27	$551,952.66	40,405	4
2024-11-04	White, William Richard	Director	-	Direct	Sale	7,136	58.26	$415,743.36	0	4
2024-10-01	White, William Richard	Director	-	Direct	Sale	201	50.88	$10,226.88	0	4
2024-09-16	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	1,500	47.41	$71,115.00	40,405	4
2024-09-03	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	1,500	50.59	$75,885.00	41,905	4
2024-09-03	White, William Richard	Director	-	Direct	Sale	1,957	50.88	$99,572.16	0	4
2024-08-01	White, William Richard	Director	-	Direct	Sale	201	43.60	$8,763.60	0	4
2024-07-01	White, William Richard	Director	-	Direct	Sale	201	45.81	$9,207.81	0	4
2024-06-17	Orbimed, Genesis Gp Llc, …	Director	-	Indirect	Purchase	83,334	36.00	$3,000,024.00	941,569	4
2024-06-17	Bitterman, Kevin	Director	-	Indirect	Purchase	222,223	36.00	$8,000,028.00	420,549	4
2024-06-17	Ashiya, Mona	Director	-	Indirect	Purchase	83,334	36.00	$3,000,024.00	941,569	4
2024-06-03	White, William Richard	Director	-	Direct	Sale	1,957	35.99	$70,432.43	0	4
2024-05-01	White, William Richard	Director	-	Direct	Sale	201	28.82	$5,792.82	0	4
2024-04-11	White, William Richard	Director	-	Direct	Sale	2,560	31.98	$81,868.80	0	4
2024-03-05	Bitterman, Kevin	Director	-	Indirect	Sale	26,157	73.50	$1,922,539.50	677,503	4
2024-01-23	Atlas, Venture Associates…	TenPercentOwner	-	Direct	Sale	47,500	67.65	$3,213,375.00	1,402,186	4
2024-01-23	Bitterman, Kevin	Director	-	Indirect	Sale	102,500	67.65	$6,934,125.00	198,326	4
2024-01-10	Bitterman, Kevin	Director	-	Indirect	Sale	20,000	64.00	$1,280,000.00	786,160	4
2024-01-10	Atlas, Venture Associates…	TenPercentOwner	-	Direct	Sale	30,000	64.00	$1,920,000.00	1,449,686	4
2023-12-18	Orbimed, Genesis Gp Llc, …	Director	-	Direct	Sale	1,724	59.24	$102,129.76	0	4
2023-12-18	Ashiya, Mona	Director	-	Direct	Sale	1,724	59.24	$102,129.76	0	4
2023-12-14	Ashiya, Mona	Director	-	Indirect	Sale	433,200	56.75	$24,584,100.00	224,405	4
2023-12-14	Bitterman, Kevin	Director	-	Indirect	Sale	20,549	59.00	$1,212,391.00	806,160	4
2023-12-14	Orbimed, Genesis Gp Llc, …	Director	-	Indirect	Sale	433,200	56.75	$24,584,100.00	224,405	4
2023-12-14	Atlas, Venture Associates…	TenPercentOwner	-	Direct	Sale	30,825	59.00	$1,818,675.00	1,479,686	4
2023-12-14	Orbimed, Genesis Gp Llc, …	Director	-	Indirect	Sale	200	57.73	$11,546.00	727,807	4
2023-12-13	Ashiya, Mona	Director	-	Indirect	Sale	106,700	58.56	$6,248,352.00	281,505	4
2023-12-12	Bryce, Joanne	Officer	Chief Financial Officer	Direct	Sale	2,500	65.22	$163,050.00	2,500	4
2023-12-12	White, William Richard	Director	-	Direct	Sale	33,511	63.63	$2,132,304.93	0	4
2023-12-05	Bryce, Joanne	Officer	Chief Financial Officer	Direct	Sale	2,541	56.30	$143,058.30	2,500	4
2023-11-22	Khara, Rahul	Officer	General Counsel	Direct	Sale	10,000	51.04	$510,400.00	0	4
2023-11-14	Khara, Rahul	Officer	General Counsel	Direct	Sale	4,900	50.79	$248,871.00	0	4
2023-11-03	Khara, Rahul	Officer	General Counsel	Direct	Sale	100	50.00	$5,000.00	0	4
2023-09-16	Atlas, Venture Fund X, L.…	TenPercentOwner	-	Direct	Sale	2,115	53.22	$112,560.30	1,593,785	4
2023-09-01	Bryce, Joanne	Officer	Chief Financial Officer	Direct	Sale	1,000	52.99	$52,990.00	1,260	4
2023-08-15	Bitterman, Kevin	Director	-	Indirect	Sale	72,931	52.40	$3,821,584.40	882,224	4
2023-08-15	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	7,672	53.16	$407,843.52	0	4
2023-08-15	Atlas, Venture Associates…	TenPercentOwner	-	Direct	Sale	111,069	52.40	$5,820,015.60	1,951,234	4
2023-08-09	Savage, William Jacob	Officer	Chief Medical Officer	Direct	Sale	8,269	50.01	$413,532.69	7,672	4
2023-08-01	Bryce, Joanne	Officer	Chief Financial Officer	Direct	Sale	4,521	50.06	$226,321.26	1,260	4
2023-06-30	Macdonald, Brian Richard	Officer	Chief Innovation Officer	Direct	Sale	4,924	45.69	$224,977.56	12,276	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

101.06%

Inst. Shares: 38,897,813

Shares Outstanding: 38,491,433

2025-12-31

103.04%

Inst. Shares: 36,368,630

Shares Outstanding: 35,295,663

2025-09-30

93.22%

Inst. Shares: 32,795,125

Shares Outstanding: 35,178,691

2025-06-30

92.33%

Inst. Shares: 32,337,243

Shares Outstanding: 35,024,592

2025-03-31

95.02%

Inst. Shares: 31,666,575

Shares Outstanding: 33,324,745

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	38,897,813	38,491,433	101.06%
2025-12-31	36,368,630	35,295,663	103.04%
2025-09-30	32,795,125	35,178,691	93.22%
2025-06-30	32,337,243	35,024,592	92.33%
2025-03-31	31,666,575	33,324,745	95.02%
2024-12-31	25,049,853	27,606,022	90.74%
2024-09-30	26,082,409	29,935,551	87.13%
2024-06-30	26,382,937	25,649,043	102.86%
2024-03-31	21,100,804	24,809,869	85.05%
2023-12-31	19,475,644	22,315,877	87.27%
2023-09-30	19,261,066	24,316,817	79.21%
2023-06-30	18,971,399	21,484,955	88.30%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Disc Medicine, Inc. (IRON) — SEC Financial Statements & Analysis

Disc Medicine, Inc. (IRON) is a pharmaceutical preparations company. Disc Medicine, Inc. trades on Nasdaq as: IRON. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Disc Medicine, Inc. reported a Debt-to-Equity ratio of 0.14x, a Price-to-Book (P/B) ratio of 4.39x (TTM), at a market cap of $2.83B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.14x
P/B TTM: 4.39x
Market Cap: $2.83B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Disc Medicine, Inc. in?

Disc Medicine, Inc. (IRON) operates in the Pharmaceutical Preparations industry.

What is IRON's market cap?

Disc Medicine, Inc. (IRON) has a market capitalization of $2.83B as of 2026-06-30.

What exchange does IRON trade on?

Disc Medicine, Inc. (IRON) trades on the Nasdaq.